Researchers have discovered that one-third of the Pfizer vaxxes administered to the unsuspecting population in Europe may have been placebos.
Scientists have uncovered startling evidence that a substantial portion of the batches of the Pfizer-BioNTech COVID-19 vaccine deployed in the European Union may in fact have consisted of placebos – and that the German regulator knew this and did not subject them to quality-control testing.
The scientists, Dr. Gerald Dyker, Professor of Organic Chemistry at the Ruhr University Bochum, and Dr. Jörg Matysik, Professor of Analytical Chemistry at the University of Leipzig, are part of a group of five German-speaking scientists who have been publicly raising questions about the quality and safety of the BioNTech vaccine (as it is known in Germany) for the last year and a half…
On Dyker’s calculation, the blue batches represent less than 5% of the total number of doses included in the Danish study. Nonetheless, they are associated with nearly 50% of the 579 deaths recorded in the sample.
Finally, we have the ‘yellow batches’ clustered around the yellow line, which, as can be seen above, barely gets off the x-axis. On Dyker’s calculation, the yellow batches represent around 30% of the total. Dyker notes that they include batches comprising some 200,000 administered doses which are associated with literally zero suspected adverse events.
As Dyker puts it, “malicious” observers might note that “this is how placebos would look”.
This is actually very good news, and might go a long way toward explaining why the adverse effects of the vaxx have not been as widespread as feared.